Skip to main navigation
Skip to search
Skip to main content
Manipal Academy of Higher Education, Manipal, India Home
Help & FAQ
Home
Profiles
Research units
Research output
Equipment
Search by expertise, name or affiliation
Botulinum toxin in high-risk BPH patients in retention
Sreedhar Reddy
*
,
Arun Chawla
, Joseph Thomas
*
Corresponding author for this work
Department of Urology, Kasturba Medical College, Manipal
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Botulinum toxin in high-risk BPH patients in retention'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
INIS
risks
100%
patients
100%
toxins
100%
retention
100%
prostate
42%
volume
28%
injection
28%
surgery
28%
zones
14%
urine
14%
anesthesia
14%
men
14%
refractories
14%
Medicine and Dentistry
Prostate Hypertrophy
100%
Botulinum Toxin A
100%
Clostridium Botulinum Type A
100%
Outpatient
50%
Prospective Study
50%
Urination
50%
Urinary Retention
50%
Residual Urine
50%
Pharmacology, Toxicology and Pharmaceutical Science
Botulinum Toxin A
100%
Prostate Hypertrophy
100%
Clostridium Botulinum Type A
100%
Prospective Study
50%
Residual Urine
50%
Urine Retention
50%